Results 21 to 30 of about 17,920 (197)
IgE autoantibodies and their association with the disease activity and phenotype in Bullous Pemphigoid: a systematic review [PDF]
, 2017 Bullous Pemphigoid (BP) is the most common autoimmune skin disease of blistering character. The underlying pathophysiological mechanism involves an immune attack, usually by IgG class autoantibodies, on the autoantigen BP 180/BPAg2, which is a type XVII ...
Fairclough, Lucy C. +3 more
core +2 more sources
Pemphigoid diseases in infancy and childhood. A review of the literature
Przegląd Dermatologiczny, 2023 Bullous pemphigoid is an autoimmune blistering disease that very rarely affects children. Clinical differences in locations of skin lesions led to the distinction of infantile versus childhood pemphigoid. Mucous membranes can be affected.
Magdalena Jałowska +2 more
doaj +1 more source
SAGE Open Medical Case Reports, 2022 Bullous pemphigoid is an acquired autoimmune blistering dermatosis that is commonly associated with high morbidity and mortality. New-onset bullous pemphigoid following vaccinations has rarely been reported in the literature.
Vincent Wan +3 more
doaj +1 more source
Paraneoplastic bullous pemphigoid – A sign of clear cell renal carcinoma
Urology Case Reports, 2020 Paraneoplastic bullous pemphigoid is a rare paraneoplastic syndrome. Rash is pruritic, with erythematous eruption of large subepidermal bullae over skin and often mucosal surfaces.
Stuart R. Jackson +5 more
doaj +1 more source
Bullous pemphigoid in infants: characteristics, diagnosis and treatment [PDF]
, 2014 BACKGROUND: Bullous pemphigoid (BP) in infants is a rare but increasingly reported autoimmune blistering skin disease. Autoantibody reactivity is usually poorly characterized. Current guidelines do not address specific aspects of the infantile form of BP.
Agnes Schwieger-Briel +8 more
core +2 more sources
Systemic lupus erythematosus and bullous pemphigoid with dramatic response to dapsone [PDF]
, 2017 Objective: Unusual clinical course Background: Bullous pemphigoid is an autoimmune blistering disease, with relapses, isolated or associated with other autoimmune diseases such as systemic lupus erythematosus (SLE).
Cimaz, R. +3 more
core +2 more sources
JEADV Clinical Practice, 2023 Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed.
Shin Iinuma +2 more
doaj +1 more source
Bullous Pemphygoid and Novel Therapeutic Approaches
Biomedicines, 2022 Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies (auto-ab) to BP180 and BP230 which affects elderly patients, predominately.
Giovanni Marco D’Agostino +10 more
doaj +1 more source
Eosinophilic dermatosis of hematologic malignancy: a case report [PDF]
, 2020 Eosinophilic dermatosis of hematologic malignancy (EDHM) is a dermatosis characterized by tissue eosinophilia that has been previously reported as insect bite-like reaction.
Almeida, FT +4 more
core
Suprachoroidal Hemorrhage with Delayed Rebleeding as the First Presentation of Bullous Pemphigoid Associated Acquired Hemophilia [PDF]
, 2016 published_or_final_versio
Choy, NKB +4 more
core +1 more source